how tirzepatide works in the body Medical Weight Loss & GLP-1 Study sees potential benefits of

Some observational data and animal model research has suggested GLP-1 receptor agonists may have direct bone-protective signaling effects that could modulate long-term fracture risk

131,132 TCR deficiency leads to an increase in hepatocyte apoptosis and significant inhibition of hepatocyte replication, and T cell deficiency induces a compromised mechanism to increase the number of T cells involved in the liver regeneration process

And they act on appetite-regulation centers in the hypothalamus, reducing hunger signals at a neurological level

At baseline, patients had type 2 diabetes for an average of 8.8 years and had a mean HbA1c of 8.2%

Some worry about GLP-1 weight regain if treatment stops, which can add hidden costs later

11 Once target HbA 1c levels have been achieved, repeat measurement every six months and complete a diabetes review annually